RSS Feeds
Search

Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Successes and Failures for Avastin (Bevacizumab) mean Mixed News for the Blockbuster Drug in the Oncology Therapeutics Market
May 2011 - 7 pages - $500
Lixte Biotechnology Holdings, Inc. - Strategic SWOT Analysis Review
Dec 2010 - 18 pages - $125
Positron Emission Tomography (PET) Markets
Dec 2007 - 90 pages - $1,999
Lixte Biotechnology Holdings, Inc. (LIXT) - Strategic SWOT Analysis Review
Feb 2011 - 17 pages - $125
Lixte Biotechnology Holdings, Inc. (LIXT) - Strategic SWOT Analysis Review
May 2011 - 20 pages - $125
Brain Cancer - Pipeline Review, Q3 2011
Jul 2011 - 327 pages - $500
Glioblastoma Multiforme - Pipeline Review, Q1 2011
Jan 2011 - 112 pages - $500
Carl Zeiss Meditec AG: Premium Company Profile
Apr 2008 - 42 pages - $495
SomaLogic, Inc. - Product Pipeline Analysis
Mar 2011 - 23 pages - $750
US Oncology, Inc. - SWOT Analysis
Nov 2010 - 26 pages - $125
More Related Market Research Reports >>>

Your selection

Industry sector
Biotechnology del
Diagnostic test systems del
Therapeutic target
Oncology del
Brain cancer del
Glioblastoma del
Year
2002 del

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us